Angiodynamics Inc's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Angiodynamics Inc's ROI in the fourth quarter of 2026?
Angiodynamics Inc recorded a cumulative net loss of $-37 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on investment (ROI) of -18.64%.

Within the Healthcare sector Angiodynamics Inc achieved the highest return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2026 from 2349 to 3165.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(May 31 2026) IV. Quarter	(Feb 28 2026) III. Quarter	(Nov 30 2025) II. Quarter	(Aug 31 2025) I. Quarter	(May 31 2025) IV. Quarter
Y / Y Investment Change TTM	-6.74 %	-7.32 %	-8.55 %	-25.58 %	-36.91 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	192	195	204	197	204
Return On Investment (TTM)	-18.64 %	-15.7 %	-13.64 %	-15.46 %	-16.08 %
ANGO's Overall Ranking	# 3165	# 2349	# 2454	# 2865	# 2873
Seq. Investment Change TTM	-1.44 %	-1.58 %	-2.13 %	-1.77 %	-2.05 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-37	-31	-28	-32	-34

ANGO Company Profile >> Back to ANGO Roi Comparisons >> See Annual ANGO Return On Investment

Return On Investment ANGO's Ranking
Within:	No.
Industry	# 1
Sector	# 1
Overall	# 3165

Return On Investment Statistics
High	Average	Low
8.55 %	-10.27 %	-101.53 %
(May 31 2019)		(Nov 30 2024)

Financial Statements
Angiodynamics Inc's IV. Quarter Investments	$ 192 Millions	ANGO's Balance sheet
Angiodynamics Inc's IV. Quarter Income	$ -11 Millions	Quarterly ANGO's Income Statement
ANGO's Income by Division		See ANGO's Income by Division

ANGO Annual Return On Investment	(May 31 2026) 2026	(May 31 2025) 2025	(May 31 2024) 2024	(May 31 2023) 2023	(May 31 2022) 2022
Total Investments in Millions	192	200	222	449	462
Y / Y Investment Growth	-3.72 %	-9.83 %	-50.61 %	-2.94 %	-4.44 %
Net Income in Millions	-37	-34	-184	-52	-27
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-19.09 %	-17.01 %	-83.17 %	-11.68 %	-5.74 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ANGO's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ANGO's Competitors
Subscribers only: Roi for Angiodynamics Inc's Suppliers
Subscribers only: Return On Investment for ANGO's Customers

Other Ratios
ANGO's Roa	ANGO's Inventory Turnover Ratio	ANGO's Growth Rates	ANGO's Dividend Statistics
	ANGO's Profitability Ratios	ANGO's Asset Turnover Ratio	ANGO's Dividend Growth
ANGO's Roe	ANGO's Valuation Ratios	ANGO's Financial Strength Ratios	ANGO's Dividend Payout Ratio

Companies with similar Return On Investment at May 31 2026, within Healthcare Sector

ROI

Date modified: 2026-09-08T15:22:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.